The identification of risk factors for cardiovascular disease prompts questions about the organization and implementation of risk factor modification programs. Are resources better spent on treating cardiovascular disease or preventing it? Should programs be adopted that screen all persons for risk factors or should the efforts be targeted to certain patient groups? Should all risk factors receive equal attention or are resources better directed toward certain risk factors? How can these different strategies be compared? These questions are difficult to answer and, in many cases, cannot be resolved easily. One method of addressing these questions is to compare the costs and benefits of alternative uses of health care resources.
KeywordsCoronary Heart Disease Smoking Cessation Ideal Body Weight Cholesterol Reduction Risk Factor Modification
Unable to display preview. Download preview PDF.
- 3.National Cholesterol Education Program: Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Washington, DC: US Department of Health and Human Services; 1993. [NIH publication no. 93–3095.]Google Scholar
- 9.Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 394: 1383–1389.Google Scholar
- 17.Downs JR, Clearfield M, Weis S, et al.: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of the AFCAPS/TexCAPS. JAMA 1998, 279:1615–1622.Google Scholar
- 24.Bartlett JC, Miller LS, Rice DP, Max WB: Medical-care expenditures attributable to cigarette smoking: United States, 1993. MMWR 1994, 43: 469–472.Google Scholar
- 25.Lightwood JM, Glantz SA: Short-term economic and health benefits of smoking cessation. J Am Coll Cardio11997, 96:1089–1096.Google Scholar